RSP provides equal-weight exposure to all S&P 500 companies, reducing concentration in overvalued mega-cap tech and imposing systematic rebalancing discipline for long-term holding.
RSP provides equal-weight exposure to all S&P 500 companies, reducing concentration in overvalued mega-cap tech and imposing systematic rebalancing discipline for long-term holding.
Author recommends PSIL as a diversified vehicle to capture the anticipated M&A wave and institutional acceptance of psychedelic therapies, with a long-term price target above $100.
Author recommends PSIL as a diversified vehicle to capture the anticipated M&A wave and institutional acceptance of psychedelic therapies, with a long-term price target above $100.